Understanding the pharmacology of microbiome-based therapeutics is required to support the development of new medicines. Strains of E. coli Nissle (EcN) were genetically modified and administered to cynomolgus monkeys at doses of 1 × 10 and 1 × 10 colony-forming units (CFU)/day for 28 days. A clinical study to evaluate the exposure and clearance of EcN in healthy volunteers was also performed. Healthy subjects received oral doses of EcN, 2.5 to 25 × 10 CFU 3 times daily for 28 days or a single day. In cynomolgus monkeys, replicating strains yielded higher fecal concentrations than nonreplicating strains and persisted for longer following cessation of dosing. In the clinical study, all subjects cleared EcN following cessation of dosing with median clearance of 1 week. Quantitative methodology can be applied to microbiome-based therapeutics, and similar kinetics and clearance were observed for EcN in cynomolgus monkeys and humans.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866967 | PMC |
| http://dx.doi.org/10.1111/cts.12528 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Basic Science and Pathogenesis.
Alzheimers Dement
December 2024
University of Massachusetts Chan Medical School, Worcester, MA, USA.
Background: In Alzheimer's disease (AD), changes in intestinal microbiota and systemic inflammation are concomitant with neuroinflammation and cognitive decline. This has led to the theory of microbial communities or infections as being causative in the development of neuroinflammation and immunosenescence seen in AD. Our research has demonstrated a decreased taxonomic diversity and an increased abundance of pathobionts in the gut of AD patients (Haran, mBio 2019), which is sufficient to promote amyloid and tau deposition in a mouse model (Chen, Gut 2023).
View Article and Find Full Text PDFRevisiting the role of pathogen diversity and microbial interactions in honeybee susceptibility and treatment of infection.
Front Vet Sci
December 2024
Department of Molecular and Cellular Biology, University of Guelph, Guelph, ON, Canada.
European Foulbrood (EFB) is a severe bacterial disease affecting honeybees, primarily caused by the Gram-positive bacterium . Although the presence of is associated with EFB, it does not consistently predict the manifestation of symptoms, and the role of 'secondary invaders' in the disease's development remains a subject of ongoing debate. This review provides an updated synthesis of the microbial ecological factors that influence the expression of EFB symptoms, which have often been overlooked in previous research.
View Article and Find Full Text PDFGut microbiome and orthopaedic health: Bridging the divide between digestion and bone integrity.
World J Orthop
December 2024
Department of Orthopaedics, Brazilian Institute of Regenerative Medicine, Indaiatuba 13334-170, São Paulo, Brazil.
The gut microbiome, a complex ecosystem of microorganisms in the digestive tract, has emerged as a critical factor in human health, influencing metabolic, immune, and neurological functions. This review explores the connection between the gut microbiome and orthopedic health, examining how gut microbes impact bone density, joint integrity, and skeletal health. It highlights mechanisms linking gut dysbiosis to inflammation in conditions such as rheumatoid arthritis and osteoarthritis, suggesting microbiome modulation as a potential therapeutic strategy.
View Article and Find Full Text PDFThe interplay of gut microbiota and heavy metals in multiple sclerosis patients.
Microb Pathog
December 2024
Department of Biology, Faculty of Science, Arak University, Arak, 38156-8-8349, Iran.
Article Synopsis
- Multiple Sclerosis (MS) patients show significantly higher concentrations of heavy metals like arsenic, nickel, manganese, and zinc in their stool compared to healthy individuals, while levels of iron, lead, titanium, and tin are notably lower.
- The study also reveals alterations in the gut microbiome of MS patients, with increased abundance of certain bacterial families indicative of potential changes associated with the disease.
- The research highlights a novel approach by combining heavy metal measurement and gut microbiome analysis, suggesting new insights into the disease's pathogenesis and possible therapeutic strategies.
IUPHAR review: Targeted therapies of signaling pathways based on the gut microbiome in autism spectrum disorders: Mechanistic and therapeutic applications.
Pharmacol Res
December 2024
Central Laboratory of The Lishui Hospital of Wenzhou Medical University, The First Affiliated Hospital of Lishui University, Lishui People's Hospital, Lishui, Zhejiang 323000, China; Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325000, China; Department of Wound Healing, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, China. Electronic address:
Autism spectrum disorders (ASD) are complex neurodevelopmental disorders characterized by impairments in social interaction, communication and repetitive activities. Gut microbiota significantly influences behavior and neurodevelopment by regulating the gut-brain axis. This review explores gut microbiota-influenced treatments for ASD, focusing on their therapeutic applications and mechanistic insights.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!